From 2015 to 2017, the global agrochemical industry underwent an epic consolidation, resulting in a structure where the "Big Six" (Syngenta, Monsanto, Bayer, Dow, DuPont, BASF) monopolized 70% of the global pesticide market and 50% of the seed market. However, during this time, Chinese companies found themselves trapped in the dual predicament of technological lag and market marginalization. Against this backdrop, in 2017, China National Chemical Corporation (ChemChina) acquired Swiss Syngenta for a total cost of 44 billion, setting a record for overseas acquisitions by Chinese enterprises and shocking the world. The primary motivation of this acquisition is to gain sustainable technological innovation capabilities and international regulatory discourse power, such as global registration certificates. The deal structure design and post-acquisition integration process provide valuable insights for other firms in the agriculture industry. This acquisition reflects China's strategic determination to break the bottleneck in the seed industry amid tight constraints on arable land and increasing population pressures.
Chenfei Li (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: